Short and Tall Ragweed Mix (Dose Level 1)

Short and Tall Ragweed Mix (Dose Level 1) is an investigational allergen immunotherapy developed by Woodmont Pharmaceuticals for the treatment of ragweed-induced allergic conjunctivitis and seasonal allergic rhinitis. This specific formulation represents a defined dose level evaluated in a Phase 1 clinical trial (NCT03038971). The product consists of extracts from short (*Ambrosia artemisiifolia*) and tall (*Ambrosia trifida*) ragweed. It is administered via four monthly intralymphatic node injections, a novel route designed to directly target the lymphatic system to induce immune tolerance more efficiently than traditional subcutaneous or sublingual methods. The therapy aims to modulate the immune system's response to ragweed allergens, potentially providing long-term relief from allergic symptoms by inducing desensitization.

Other names

Short and Tall Ragweed MixRagweed MixShort and Tall Ragweed Allergen Extract